QuickView for lung-associated mesenchyme development (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. Pediatric (fetal and embryonal) hepatoblastomas and adult hepatocellular carcinomas
5. L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts

There were no matches for lung-associated mesenchyme development

1. Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchyma…
2. Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Inf…
3. Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome
4. Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
5. Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19